DIVERSIFIED HEALTHCARE TRUST
DHCNasdaqReal Estate · Real Estate Investment Trusts · MD · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.54B | $1.50B | $1.41B | $1.28B | $1.38B | $1.63B |
| Operating income | — | — | — | — | — | — |
| Net income | −$285.9M | −$370.3M | −$293.6M | −$15.8M | $174.5M | −$139.5M |
| Total assets | $4.36B | $5.14B | $5.45B | $6.00B | $6.62B | $6.48B |
| Total liabilities | $2.70B | $3.18B | $3.11B | $3.36B | $3.96B | $3.86B |
| Equity | $1.67B | $1.96B | $2.34B | $2.64B | $2.66B | $2.50B |
| EPS (diluted) | $-1.19 | $-1.55 | $-1.23 | $-0.07 | $0.73 | $-0.59 |
| Shares out. | 241.3M | 240.4M | 239.7M | 239.0M | 238.3M | 237.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- −18.6%
- Return on equity
- −17.2%
- Return on assets
- −6.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 61.8%
- Debt / equity
- 1.62×
- Book value / share
- $6.90
- Revenue growth (YoY)
- 2.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −6.1%clean
- Piotroski F-Score
- 4/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 warning● 2 good- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Group IncPassive (13G)Mar 26, 2026
- Flat Footed LlcPassive (13G)Oct 22, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Bilotto Christopher J.Officer — President and CEO | Dec 15, 2025 | Buy | 20,000 | $4.89 |
| Brown Matthew C.Officer — CFO and Treasurer | Sep 16, 2025 | Tax withholding | 9,711 | $4.37 |
| Bilotto Christopher J.Officer — President and CEO | Sep 16, 2025 | Tax withholding | 17,091 | $4.37 |
| Portnoy Adam D.Director | Sep 16, 2025 | Tax withholding | 15,226 | $4.37 |
| Portnoy Adam D.Director | Sep 9, 2025 | Grant | 81,775 | — |
| Bilotto Christopher J.Officer — President and CEO | Sep 9, 2025 | Grant | 81,775 | — |
| Brown Matthew C.Officer — CFO and Treasurer | Sep 9, 2025 | Grant | 37,383 | — |
| Felder Alan L.Director | May 29, 2025 | Grant | 29,141 | — |
| Hollis Phyllis M.Director | May 29, 2025 | Grant | 29,141 | — |
| Neher Dawn K.Director | May 29, 2025 | Grant | 29,141 | — |
| Bilotto Christopher J.Officer — President and CEO | May 29, 2025 | Grant | 29,141 | — |
| Portnoy Adam D.Director | May 29, 2025 | Grant | 29,141 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 9.3M | 5.6 | -4.8% |
| Apr 30, 2026 | 9.8M | 8.1 | +4.7% |
| Apr 15, 2026 | 9.4M | 6.3 | +7.3% |
| Mar 31, 2026 | 8.7M | 3.7 | +16.1% |
| Mar 13, 2026 | 7.5M | 3.0 | +20.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureJun 1, 2026
- Regulation FD disclosureMay 5, 2026
- Results of operationsMay 4, 2026
- Regulation FD disclosureFeb 24, 2026
- Results of operationsFeb 23, 2026
- Results of operations · Other material eventJan 14, 2026
- Terminated a material agreementJan 5, 2026
- Regulation FD disclosureDec 8, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KJun 1, 2026
- 8-KFORM 8-KMay 5, 2026
- 10-QMay 4, 2026
- 8-KMay 4, 2026
- SCHEDULE 13G/AMar 26, 2026
- DEFA14AMar 25, 2026
- DEFA14AMar 19, 2026
- DEF 14AMar 19, 2026
- ARSMar 19, 2026
- 8-KFORM 8-KFeb 24, 2026
- 10-KFeb 24, 2026
- 8-KFeb 23, 2026
- 8-KFORM 8-KJan 14, 2026
- 8-KFORM 8-KJan 5, 2026
- 4OWNERSHIP DOCUMENTDec 16, 2025